1 week Ago By ABMN Staff
JPMorgan Chase & Co. reduced its stake in Establishment Labs Holdings Inc. ( NASDAQ:ESTA – Free Report ) by 38.
7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 554,061 shares of the company’s stock after selling 349,354 shares during the period. JPMorgan Chase & Co.
’s holdings in Establishment Labs were worth $25,526,000 as of its most recent SEC filing. Several other hedge funds have also bought and sold shares of ESTA. William Blair Investment Management LLC increased its holdings in shares of Establishment Labs by 44.
1% in the fourth quarter. William Blair Investment Management LLC now owns 812,825 shares of the company’s stock worth $37,447,000 after purchasing an additional 248,888 shares during the last quarter. Assenagon Asset Management S.
A. purchased a new position in Establishment Labs during the 4th quarter valued at approximately $12,898,000. Raymond James Financial Inc.
bought a new stake in Establishment Labs in the 4th quarter worth approximately $5,494,000. Royce & Associates LP purchased a new stake in shares of Establishment Labs during the 4th quarter worth approximately $4,862,000. Finally, Simplify Asset Management Inc.
boosted its position in shares of Establishment Labs by 197.1% during the 4th quarter. Simplify Asset Management Inc.
now owns 64,300 shares of the company’s stock valued at $2,962,000 after acquiring an additional 42,661 shares during the last quarter. Hedge funds and other institutional investors own 72.91% of the company’s stock.
Wall Street Analysts Forecast Growth Separately, Stephens restated an “overweight” rating and issued a $52.00 price target on shares of Establishment Labs in a research report on Thursday, March 6th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company.
Based on data from MarketBeat.com, Establishment Labs has a consensus rating of “Moderate Buy” and an average price target of $57.40.
Establishment Labs Trading Down 12.7 % Shares of ESTA stock opened at $27.31 on Wednesday.
The company has a market cap of $787.78 million, a PE ratio of -10.59 and a beta of 0.
77. Establishment Labs Holdings Inc. has a 1 year low of $26.
96 and a 1 year high of $60.12. The stock’s 50 day simple moving average is $36.
38 and its two-hundred day simple moving average is $40.32. The company has a debt-to-equity ratio of 5.
94, a current ratio of 3.62 and a quick ratio of 2.29.
Establishment Labs ( NASDAQ:ESTA – Get Free Report ) last issued its quarterly earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.
64) by ($0.34). The company had revenue of $44.
51 million during the quarter, compared to the consensus estimate of $44.45 million. Establishment Labs had a negative return on equity of 184.
55% and a negative net margin of 46.13%. Research analysts predict that Establishment Labs Holdings Inc.
will post -2.41 earnings per share for the current year. About Establishment Labs ( Free Report ) Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery.
The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. Featured Stories Want to see what other hedge funds are holding ESTA? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Establishment Labs Holdings Inc. ( NASDAQ:ESTA – Free Report ). Receive News & Ratings for Establishment Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs and related companies with MarketBeat.
com's FREE daily email newsletter ..
